Get the Stockscreener App
1.025
4.67%
-0.045
After Hours:
1.03
0.005
+0.49%
Talphera Inc stock is traded at $1.025, with a volume of 267.69K.
It is down -4.67% in the last 24 hours and up +27.50% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.07
Open:
$1.07
24h Volume:
267.69K
Relative Volume:
1.50
Market Cap:
$53.20M
Revenue:
$28,000
Net Income/Loss:
$-14.36M
P/E Ratio:
-2.8237
EPS:
-0.363
Net Cash Flow:
$-11.36M
1W Performance:
-6.42%
1M Performance:
+27.50%
6M Performance:
-7.27%
1Y Performance:
+131.82%
1-Day Range:
$0.99
$1.07
1-Week Range:
$0.9691
$1.13
52-Week Range:
$0.38
$1.57
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
1.025 | 55.53M | 28,000 | -14.36M | -11.36M | -0.363 |
TAK
Takeda Pharmaceutical Co Adr
|
15.92 | 49.45B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 40.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.22 | 39.15B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.05 | 32.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
542.28 | 23.07B | 3.17B | 1.29B | 1.01B | 27.09 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Talphera, Inc. Actuals & Estimates (NASDAQ:TLPH) - TradingView
Form 4 Talphera Inc For: 24 June By Investing.com - Investing.com Canada
Director at TALPHERA (TLPH) receives RSUs and stock options - Stock Titan
[Form 4] TALPHERA, INC. Insider Trading Activity - Stock Titan
TALPHERA (TLPH) director granted 5,100 shares and 30,700 options - Stock Titan
TALPHERA (TLPH) director Stephen Hoffman granted 5,100 shares and 30,700 options - Stock Titan
TALPHERA (TLPH) director Broadfoot granted RSUs and 30,700 stock options - Stock Titan
Talphera (NASDAQ: TLPH) director awarded RSUs and 30,700 stock options - Stock Titan
TALPHERA (NASDAQ: TLPH) director receives RSU and option grants - Stock Titan
Talphera's Market Cap Up US$6.7m Following Year Of Insider Stock Buying - simplywall.st
Talphera, Inc. 2026 Annual Meeting Results: Stockholders Approve Amended 2020 Equity Incentive Plan and 2011 Employee Stock Purchase Plan – Minichart - Minichart
Talphera Inc (TLPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Talphera shareholders approve director elections and equity plan amendments - Investing.com
Talphera shareholders approve director elections and equity plan amendments By Investing.com - Investing.com South Africa
Form 8K Talphera Inc For: 23 June By Investing.com - Investing.com South Africa
Shareholders at Talphera (NASDAQ: TLPH) approve directors, auditor and updated equity plans - Stock Titan
Talphera Inc (TLPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TLPH: All proposals, including director elections and plan amendments, were approved without shareholder questions - TradingView
Talphera Inc (TLPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Talphera Inc (TLPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Talphera Inc (TLPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Talphera Inc (TLPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Talphera Inc (TLPH) Institutional Confidence - TradingKey
Talphera Inc (TLPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Talphera Inc (TLPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TLPH Q1 2026 Earnings: Narrowed Loss Beats Expectations, No Revenue ReportedFinal Results - newsline.com
TLPH Q1 2026 Earnings: EPS Beat on Narrower Loss; Stock Dips 3%Earnings Expansion Phase - newsline.com
TLPH Q1 2026 Earnings: EPS Beat on Narrower-Than-Expected LossHigh Growth Earnings - newsline.com
TLPH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise, Stock SlipsEarnings Quality Score - newsline.com
TLPH Assumed by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
H.C. Wainwright Maintains Talphera(TLPH.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
H.C. Wainwright initiates Talphera stock coverage with buy rating By Investing.com - Investing.com India
H.C. Wainwright initiates Talphera stock coverage with buy rating - Investing.com
Talphera Q3 2025 Earnings Preview - MSN
TLPH Q1 2026 Earnings: Narrower-than-Expected Loss Despite Minimal RevenueEarnings Per Share - newsline.com
Talphera Inc. (TLPH) Sees Modest Decline as Shares Trade Near Key Support at $0.78Liquidity Sweep - The Legal Advocate
What Does CEO Vincent Angotti's Recent Stock Purchase Signal - Kavout
Talphera Inc. (TLPH) Slides 1.95%, Nears Key Support at $0.77 Amid ConsolidationValue Stock Ideas - newsline.com
TLPH Q1 2026 Earnings: Significant EPS Beat as Pre‑Revenue Biotech Advances PipelineROA Comparison - newsline.com
Talphera Trades Around 80 Cents With Focus on Single Trial Catalyst - Bez Kabli
Talphera Inc. (TLPH) Slides 1.85% as Stock Tests Support Near $0.76Hot Stock Picks - The Legal Advocate
Talphera Inc. (TLPH) Q1 2026 Earnings: Narrower Loss Surprises Analysts as Company Advances PipelineCEO Earnings Statement - Newser
Talphera Inc. (TLPH) Edges Higher as Shares Test Key Resistance at $0.88Bollinger Expansion - Newser
TALPHERA (TLPH) CMO surrenders 4,518 shares to cover RSU tax - Stock Titan
Talphera Earnings Call Highlights NEPHRO Trial Momentum - The Globe and Mail
WestPark Capital initiates coverage of Talphera (TLPH) with buy recommendation - MSN
Talphera (TLPH) Amendment: Lytton reports 1.25M shares, 2.5% - Stock Titan
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):